Debra Yu
CIK: 0001869480
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Yu Debra
Yu Debra (SEC CIK 0001869480) files insider reports with the SEC as Director of MeiraGTx Holdings plc (MGTX) and Director of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
Signal8 holds 4 ownership filings by Yu Debra (2 Form 3, 2 Form 4), filed between Jun 16, 2025 and Jun 15, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yu Debra's filings is in NEW YORK, NY.
Recent filings by Yu Debra
Other insiders filing for MeiraGTx Holdings plc (MGTX)
- Giroux Richard, CFO & COO
- Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY
- SEBULSKY ALAN, Director
- Forbes Alexandria, PRESIDENT & CEO
- Zeldin Robert K, CHIEF MEDICAL OFFICER
- Wollin Robert J, GENERAL COUNSEL AND SECRETARY